APC Anti-MyD88 antibody [EPR590(N)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal MYD88 antibody - conjugated to APC.
View Alternative Names
Myeloid differentiation primary response protein MyD88, MYD88
Related conjugates and formulations (9)
-
HRP Anti-MyD88 antibody [EPR590(N)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-MyD88 antibody [EPR590(N)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MyD88 antibody [EPR590(N)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-MyD88 antibody [EPR590(N)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-MyD88 antibody [EPR590(N)]
-
578 PE
PE Anti-MyD88 antibody [EPR590(N)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-MyD88 antibody [EPR590(N)]
-
Anti-MyD88 antibody [EPR590(N)]
-
Anti-MyD88 antibody [EPR590(N)] - BSA and Azide free
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.
Pathways
MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com